272 related articles for article (PubMed ID: 8258416)
1. Hepatic peroxisome proliferation in rodents and its significance for humans.
Bentley P; Calder I; Elcombe C; Grasso P; Stringer D; Wiegand HJ
Food Chem Toxicol; 1993 Nov; 31(11):857-907. PubMed ID: 8258416
[TBL] [Abstract][Full Text] [Related]
2. [Proliferation of peroxisomes and the hepatocarcinogenic process].
Palut D
Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
[TBL] [Abstract][Full Text] [Related]
3. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
4. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
Chevalier S; Roberts RA
Oncol Rep; 1998; 5(6):1319-27. PubMed ID: 9769363
[TBL] [Abstract][Full Text] [Related]
5. PPAR: a mediator of peroxisome proliferator action.
Green S
Mutat Res; 1995 Dec; 333(1-2):101-9. PubMed ID: 8538617
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals.
Lake BG
Annu Rev Pharmacol Toxicol; 1995; 35():483-507. PubMed ID: 7598504
[TBL] [Abstract][Full Text] [Related]
7. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
8. Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans?
Cattley RC; DeLuca J; Elcombe C; Fenner-Crisp P; Lake BG; Marsman DS; Pastoor TA; Popp JA; Robinson DE; Schwetz B; Tugwood J; Wahli W
Regul Toxicol Pharmacol; 1998 Feb; 27(1 Pt 1):47-60. PubMed ID: 9629596
[TBL] [Abstract][Full Text] [Related]
9. Modes of action and species-specific effects of di-(2-ethylhexyl)phthalate in the liver.
Rusyn I; Peters JM; Cunningham ML
Crit Rev Toxicol; 2006 May; 36(5):459-79. PubMed ID: 16954067
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferators: their biological and toxicological effects.
Dzhekova-Stojkova S; Bogdanska J; Stojkova Z
Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454
[TBL] [Abstract][Full Text] [Related]
11. Differential induction and regulation of peroxisomal enzymes: predictive value of peroxisome proliferation in identifying certain nonmutagenic carcinogens.
Nemali MR; Reddy MK; Usuda N; Reddy PG; Comeau LD; Rao MS; Reddy JK
Toxicol Appl Pharmacol; 1989 Jan; 97(1):72-87. PubMed ID: 2916237
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferators and receptor-mediated hepatic carcinogenesis.
Cattley RC
Toxicol Pathol; 2004; 32 Suppl 2():6-11. PubMed ID: 15503658
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferation: current mechanisms relating to nongenotoxic carcinogenesis.
Lake BG
Toxicol Lett; 1995 Dec; 82-83():673-81. PubMed ID: 8597126
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor-α signaling in hepatocarcinogenesis.
Misra P; Viswakarma N; Reddy JK
Subcell Biochem; 2013; 69():77-99. PubMed ID: 23821144
[TBL] [Abstract][Full Text] [Related]
15. Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP)?
Melnick RL
Environ Health Perspect; 2001 May; 109(5):437-42. PubMed ID: 11401753
[TBL] [Abstract][Full Text] [Related]
16. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.
Lai DY
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):37-55. PubMed ID: 15845221
[TBL] [Abstract][Full Text] [Related]
17. PPARalpha agonist-induced rodent tumors: modes of action and human relevance.
Klaunig JE; Babich MA; Baetcke KP; Cook JC; Corton JC; David RM; DeLuca JG; Lai DY; McKee RH; Peters JM; Roberts RA; Fenner-Crisp PA
Crit Rev Toxicol; 2003; 33(6):655-780. PubMed ID: 14727734
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver.
Lalwani ND; Reddy MK; Qureshi SA; Sirtori CR; Abiko Y; Reddy JK
Hum Toxicol; 1983 Jan; 2(1):27-48. PubMed ID: 6840792
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferators: paradigms and prospects.
Gibson GG
Toxicol Lett; 1993 May; 68(1-2):193-201. PubMed ID: 8390728
[TBL] [Abstract][Full Text] [Related]
20. Comparison of dose-response relationships for induction of lipid metabolizing and growth regulatory genes by peroxisome proliferators in rat liver.
Belury MA; Moya-Camarena SY; Sun H; Snyder E; Davis JW; Cunningham ML; Vanden Heuvel JP
Toxicol Appl Pharmacol; 1998 Aug; 151(2):254-61. PubMed ID: 9707502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
